These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9424017)

  • 21. Synthesis and structure-activity relationships of substituted 1,4-dihydroquinoxaline-2,3-diones: antagonists of N-methyl-D-aspartate (NMDA) receptor glycine sites and non-NMDA glutamate receptors.
    Keana JF; Kher SM; Cai SX; Dinsmore CM; Glenn AG; Guastella J; Huang JC; Ilyin V; Lü Y; Mouser PL
    J Med Chem; 1995 Oct; 38(22):4367-79. PubMed ID: 7473565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of NMDA receptor antagonists on cocaine-conditioned motor activity in rats.
    Bespalov AY; Dravolina OA; Zvartau EE; Beardsley PM; Balster RL
    Eur J Pharmacol; 2000 Mar; 390(3):303-11. PubMed ID: 10708738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycine receptor antagonism. Effects of ACEA-1021 on the minimum alveolar concentration for halothane in the rat.
    McFarlane C; Warner DS; Nader A; Dexter F
    Anesthesiology; 1995 Apr; 82(4):963-8. PubMed ID: 7717569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroprotective effects of NMDA receptor glycine recognition site antagonism: dependence on glycine concentration.
    Pearlstein RD; Beirne JP; Massey GW; Warner DS
    J Neurochem; 1998 May; 70(5):2012-9. PubMed ID: 9572287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glutamate receptor antagonists block cocaine-induced convulsions and death.
    Rockhold RW; Oden G; Ho IK; Andrew M; Farley JM
    Brain Res Bull; 1991 Nov; 27(5):721-3. PubMed ID: 1684527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blockade of NMDA receptors in the nucleus accumbens elicits spontaneous tail-flicks in rats.
    Millan MJ; Audinot V; Honoré P; Bervoets K; Veiga S; Brocco M
    Eur J Pharmacol; 2000 Jan; 388(1):37-47. PubMed ID: 10657545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NBQX, an improved non-NMDA antagonist studied in retinal ganglion cells.
    Yu W; Miller RF
    Brain Res; 1995 Sep; 692(1-2):190-4. PubMed ID: 8548303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-activity relationships of alkyl- and alkoxy-substituted 1,4-dihydroquinoxaline-2,3-diones: potent and systemically active antagonists for the glycine site of the NMDA receptor.
    Cai SX; Kher SM; Zhou ZL; Ilyin V; Espitia SA; Tran M; Hawkinson JE; Woodward RM; Weber E; Keana JF
    J Med Chem; 1997 Feb; 40(5):730-8. PubMed ID: 9057859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The N-methyl-D-aspartate (NMDA) receptor glycine site antagonist ACEA 1021 does not produce pathological changes in rat brain.
    Hawkinson JE; Huber KR; Sahota PS; Han Hsu H; Weber E; Whitehouse MJ
    Brain Res; 1997 Jan; 744(2):227-34. PubMed ID: 9027382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of (R)-HA966 or ACEA 1021 on dexfenfluramine or (S)-MDMA-induced changes in temperature, activity, and neurotoxicity.
    Russell BR; Laverty R
    Pharmacol Biochem Behav; 2001 Mar; 68(3):565-74. PubMed ID: 11325413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of morphine tolerance by NMDA receptor antagonists in the formalin test.
    Lutfy K; Shen KZ; Woodward RM; Weber E
    Brain Res; 1996 Aug; 731(1-2):171-81. PubMed ID: 8883867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacology of 5-chloro-7-trifluoromethyl-1,4-dihydro-2,3-quinoxalinedione: a novel systemically active ionotropic glutamate receptor antagonist.
    Woodward RM; Huettner JE; Tran M; Guastella J; Keana JF; Weber E
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1209-18. PubMed ID: 8531083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tolerance develops to the antinociceptive and motor impairing effects of ACEA-1416, a NMDA receptor antagonist, in the formalin and rotarod test in mice.
    Lutfy K; Weber E
    Pharmacol Res; 1998 Apr; 37(4):295-302. PubMed ID: 9634646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel systemically active antagonists of the glycine site of the N-methyl-D-aspartate receptor: electrophysiological, biochemical and behavioral characterization.
    Parsons CG; Danysz W; Quack G; Hartmann S; Lorenz B; Wollenburg C; Baran L; Przegalinski E; Kostowski W; Krzascik P; Chizh B; Headley PM
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1264-75. PubMed ID: 9400002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 5-(N-oxyaza)-7-substituted-1,4-dihydroquinoxaline-2,3-diones: novel, systemically active and broad spectrum antagonists for NMDA/glycine, AMPA, and kainate receptors.
    Cai SX; Huang JC; Espitia SA; Tran M; Ilyin VI; Hawkinson JE; Woodward RM; Weber E; Keana JF
    J Med Chem; 1997 Oct; 40(22):3679-86. PubMed ID: 9357535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ACEA-1011, a novel NMDA receptor/glycine site antagonist, produces antinociception but not tolerance in the formalin test in mice.
    Lutfy K; Keana JF; Weber E
    NIDA Res Monogr; 1995; 147():220-33. PubMed ID: 8742789
    [No Abstract]   [Full Text] [Related]  

  • 37. Differential effects of five glycine site antagonists on NMDA receptor desensitisation.
    Molnár P; Erdõ SL
    Eur J Pharmacol; 1996 Sep; 311(2-3):311-4. PubMed ID: 8891614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 5-Aminomethylquinoxaline-2,3-diones, Part III: Arylamide derivatives as highly potent and selective glycine-site NMDA receptor antagonists.
    Acklin P; Allgeier H; Auberson YP; Bischoff S; Ofner S; Sauer D; Schmutz M
    Bioorg Med Chem Lett; 1998 Mar; 8(5):493-8. PubMed ID: 9871605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peripherally acting NMDA receptor/glycineB site receptor antagonists inhibit morphine tolerance.
    Danysz W; Kozela E; Parsons CG; Sladek M; Bauer T; Popik P
    Neuropharmacology; 2005 Mar; 48(3):360-71. PubMed ID: 15721168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo models of cerebral ischemia: effects of parenterally administered NMDA receptor glycine site antagonists.
    Warner DS; Martin H; Ludwig P; McAllister A; Keana JF; Weber E
    J Cereb Blood Flow Metab; 1995 Mar; 15(2):188-96. PubMed ID: 7860652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.